182
Views
7
CrossRef citations to date
0
Altmetric
Review

Deciding to Enrol in a Cancer Trial: A Systematic Review of Qualitative Studies

, , , ORCID Icon &
Pages 1257-1281 | Published online: 27 Oct 2020

References

  • World Health Organisation. Clinical trials. 2020; Available from: https://www.who.int/topics/clinical_trials/en/. Accessed October 1, 2020.
  • Unger JM, Cook E, Tai E, et al. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;35(36):185–198. doi:10.1200/EDBK_156686
  • Grand MM, O’Brien PC. Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature. J Med Imaging Radiat Oncol. 2012;56(1):31–39. doi:10.1111/j.1754-9485.2011.02337.x
  • Comis RL, Miller JD, Aldigé CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21(5):830–835. doi:10.1200/JCO.2003.02.105
  • Gerido LH, He Z. Improving patient participation in cancer clinical trials: a qualitative analysis of HSRProj & RePORTER. Stud Health Technol Inform. 2019;264:1925–1926.
  • Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228–242. doi:10.1002/cncr.23157
  • Nipp RD, Hong K, Paskett ED. Overcoming barriers to clinical trial enrollment. Am Soc Clin Oncol Educ Book. 2019;39(39):105–114. doi:10.1200/EDBK_243729
  • Mills EJ, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006;7(2):141–148. doi:10.1016/S1470-2045(06)70576-9
  • Bell JAH, Balneaves LG. Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients’ relational autonomy. Support Care Cancer. 2015;23(4):1169–1196.
  • Gillies K, Cotton SC, Brehaut JC, Politi MC, Skea Z. Decision aids for people considering taking part in clinical trials. Cochrane Database Syst Rev. 2015;11.
  • Biedrzycki. Research Participation: Decision Making and Outcomes in Cancer Clinical Trials. Johns Hopkins University; 2010:216.
  • Spittler CA. Exploration of How Women Make Treatment Decisions After a Breast Cancer Diagnosis. Ann Arbor: University of Kansas; 2011:172.
  • Truong TH, Weeks JC, Cook EF, et al. Altruism among participants in cancer clinical trials. Clin Trials. 2011;8(5):616–623. doi:10.1177/1740774511414444
  • Shah A, Efstathiou JA, Paly JJ, et al. Prospective preference assessment of patients‘ willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e13–e19. doi:10.1016/j.ijrobp.2011.11.072
  • Chow CJ, Habermann EB, Abraham A, et al. Does enrollment in cancer trials improve survival? J Am Coll Surg. 2013;216(4):774. doi:10.1016/j.jamcollsurg.2012.12.036
  • Gregersen TA, Birkelund R, Wolderslund M, et al. What matters in clinical trial decision-making: a systematic review of interviews exploring cancer patients’ experiences. Scand J Caring Sci. 2019;33(2):266–278. doi:10.1111/scs.12637
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535. doi:10.1136/bmj.b2535
  • Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45. doi:10.1186/1471-2288-8-45
  • Lachal J, Revah-Levy A, Orri M, et al. Metasynthesis: an original method to synthesize qualitative literature in psychiatry. Front Psychiatry. 2017;8:269. doi:10.3389/fpsyt.2017.00269
  • Hossain LN, Fernandez-Llimos F, Luckett T, et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9):e015471. doi:10.1136/bmjopen-2016-015471
  • Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fieldsAHFMRHTA Initiative20040213. 2004;2.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042
  • Abhyankar P, Velikova G, Summers B, et al. Identifying components in consent information needed to support informed decision making about trial participation: an interview study with women managing cancer. Soc Sci Med. 2016;161:83–91. doi:10.1016/j.socscimed.2016.05.040
  • Burke NJ. Rethinking the therapeutic misconception: social justice, patient advocacy, and cancer clinical trial recruitment in the US safety net. BMC Med Ethics. 2014;15(1):68. doi:10.1186/1472-6939-15-68
  • Cox K. Researching research: patients‘ experiences of participation in phase I and II anti-cancer drug trials. Eur J Oncol Nurs. 1999;3(3):143–152. doi:10.1016/S1462-3889(99)80705-4
  • Cox K. Informed consent and decision-making: patients’ experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Educ Couns. 2002;46(1):31–38. doi:10.1016/S0738-3991(01)00147-1
  • Coyne CA, Demian-Popescu C, Brown P. Rural cancer patients’ perspectives on clinical trials: a qualitative study. J Cancer Educ. 2004;19(3):165–169. doi:10.1207/s15430154jce1903_11
  • Davis CJ. Psychological Factors That Influence Patient Participation in Cancer Clinical Trials. (BL: DXN053473). Ann Arbor: University of Hull (United Kingdom); 2001:1.
  • Dimond DL, Holifield EA. Factors That Affect the Surgical Decision-Making Process Among Women with Breast Cancer. Ann Arbor: University of Michigan-Flint; 2009:64.
  • Ellington L, Wahab S, Sahami Martin S, et al. Factors that influence Spanish- and English-speaking participants’ decision to enroll in cancer randomized clinical trials. Psychooncology. 2006;15(4):273–284. doi:10.1002/pon.943
  • Harrop E, Kelly J, Griffiths G, et al. Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the cancer research UK BOLERO trial (bladder cancer: open versus lapararoscopic or RObotic cystectomy). Trials. 2016;17(1):35. doi:10.1186/s13063-016-1173-z
  • Haynes-Maslow L, Godley P, Dimartino L, et al. African American women’s perceptions of cancer clinical trials. Cancer Med. 2014;3(5):1430–1439. doi:10.1002/cam4.284
  • Hercinger MM. Treatment Decision-Making in Older Adults with Cancer. Ann Arbor: The University of Nebraska - Lincoln; 2007:200.
  • Hopper TM. The Lack of African-American Participation in Cancer Clinical Trials: Mistrust of Medical Researchers. Ann Arbor: Capella University; 2007:141.
  • Lee GE, Ow M, Lie D, et al. Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study. BMC Womens Health. 2016;16(1):43. doi:10.1186/s12905-016-0319-1
  • Madsen SM, Holm S, Riis P. Participating in a cancer clinical trial? The balancing of options in the loneliness of autonomy: a grounded theory interview study. Acta Oncol. 2007;46(1):49–59. doi:10.1080/02841860600911164
  • Moynihan C, Lewis R, Hall E, et al. The patient deficit model overturned: a qualitative study of patients‘ perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011). Trials. 2012;13(1):228. doi:10.1186/1745-6215-13-228
  • Palmer-Wackerly AL, Dailey PM, Krok-Schoen JL, et al. Patient perceptions of illness identity in cancer clinical trial decision-making. Health Commun. 2018;33(8):1045–1054. doi:10.1080/10410236.2017.1331189
  • Quinn GP, Pratt CL, Bryant-George K, et al. Lung cancer patients’ decisions about clinical trials and the theory of planned behavior. J Cancer Educ. 2011;26(4):641–648. doi:10.1007/s13187-010-0169-8
  • Quinn GP, Koskan A, Wells KJ, et al. Cancer patients‘ fears related to clinical trial participation: a Qualitative Study. J Cancer Educ. 2012;27(2):257–262. doi:10.1007/s13187-012-0310-y
  • Ramers-Verhoeven CW, Perrone F, Oliver K. Exploratory research into cancer patients’ attitudes to clinical trials. ecancermedicalscience. 2014;8:1.
  • Ridgeway JL, Asiedu GB, Carroll K, et al. Patient and family member perspectives on searching for cancer clinical trials: a qualitative interview study. Patient Educ Couns. 2017;100(2):349–354. doi:10.1016/j.pec.2016.08.020
  • Sanders T. Factors Influencing Treatment Decisions for Patients with Colorectal Cancer. Ann Arbor: University of Bath (United Kingdom); 2000:348.
  • Skousen T. Decision Making in a Health-Care Crisis: Men Under 60 Diagnosed with Prostate Cancer. Ann Arbor: The University of Utah; 2006:240.
  • Stevens T, Ahmedzai SH. Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study. Patient Educ Couns. 2004;52(3):341–348. doi:10.1016/S0738-3991(03)00041-7
  • Huizinga GA, Sleijfer DT, van de Wiel HBM, et al. Decision-making process in patients before entering phase III cancer clinical trials: a pilot study. Cancer Nurs. 1999;22(2):119–125. doi:10.1097/00002820-199904000-00003
  • Ebbert JA. Multiple Case Study of Factors Associated with Enrollment of Women with Persistent or Recurrent Ovarian Cancer in Clinical Trials in Central Florida. Ann Arbor: University of South Florida; 2016:219.
  • Brown RF, Cadet DL, Houlihan RH, et al. Perceptions of participation in a Phase I, II, or III clinical trial among African American patients with cancer: what do refusers say? J Oncol Pract. 2013;9(6):287–293. doi:10.1200/JOP.2013.001039
  • Godskesen T, Hansson MG, Nygren P, et al. Hope for a cure and altruism are the main motives behind participation in Phase 3 clinical cancer trials. Eur J Cancer Care (Engl). 2015;24(1):133–141. doi:10.1111/ecc.12184
  • Brown RF, Shuk E, Leighl N, et al. Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Support Care Cancer. 2011;19(8):1227–1238. doi:10.1007/s00520-010-0942-6
  • Cox K. The hopes of the dying: examining patients’ experience of participation in early phase cancer clinical trials … including commentary by Copp G. NT Res. 2002;7(1):60–74. doi:10.1177/136140960200700110
  • Dellson P, Nilsson K, Jernström H, et al. Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study. Trials. 2018;19(1):528. doi:10.1186/s13063-018-2916-9
  • Godskesen T, Nygren P, Nordin K, et al. Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation. Support Care Cancer. 2013;21(11):3137–3142. doi:10.1007/s00520-013-1891-7
  • Madsen S, Holm S, Riis P. Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a grounded theory approach. J Med Ethics. 2007;33(4):234–240. doi:10.1136/jme.2005.015255
  • Schutta KM, Burnett CB. Factors that influence a patient’s decision to participate in a phase I cancer clinical trial. Oncol Nurs Forum. 2000;27(9):1435–1438.
  • Asiedu GB, Ridgeway JL, Carroll K, Jatoi A, Radecki Breitkopf C. Ultimately, mom has the call”: viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy. Health Expect. 2018;21(6):981–9.
  • Krieger J, Palmer-Wackerly A, Dailey PM, et al. Comprehension of randomization and uncertainty in cancer clinical trials decision making among rural, appalachian patients. J Cancer Educ. 2015;30(4):743–748. doi:10.1007/s13187-015-0789-0
  • Lee GE. Factors associated with willingness to participate in clinical trials among diverse Asian patients with breast cancer. Eur J Cancer. 2016;60:e7. doi:10.1016/j.ejca.2016.03.030
  • Wallington SF, Luta G, Noone AM, et al. Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos. J Community Health. 2012;83(1):e13–e19. doi:10.1007/s10900-011-9450-y
  • Townsley CA, Chan KK, Pond GR, et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer. 2006;6(1):34. doi:10.1186/1471-2407-6-34
  • Catt S, Langridge C, Fallowfield L, et al. Reasons given by patients for participating, or not, in Phase 1 cancer trials. Eur J Cancer. 2011;47(10):1490–1497. doi:10.1016/j.ejca.2011.02.020
  • Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2008;8(1):272–282. doi:10.1016/S0197-2456(03)00020-5
  • Gordon EJ, Daugherty CK. Referral and decision making among advanced cancer patients participating in phase I trials at a single institution. J Clin Ethics. 2001;12(1):31–38.
  • Harrop JP, Dean JA, Paskett ED. Cancer survivorship research: a review of the literature and summary of current NCI-designated cancer center projects. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2042–2047. doi:10.1158/1055-9965.EPI-11-0673
  • Cox K. A Means to an End?: a Study of Patients’ Experiences of Participation in Phase I and Ii Anti-Cancer Drug Trials. Ann Arbor: The University of Nottingham (United Kingdom); 1999:1.
  • Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651–661.
  • Brehaut JC, Fergusson DA, Kimmelman J, et al. Using decision aids may improve informed consent for research. Contemp Clin Trials. 2010;31(3):218–220. doi:10.1016/j.cct.2010.02.002
  • Feldman-Stewart D, O’Brien MA, Clayman ML, et al. Providing information about options in patient decision aids. BMC Med Inform Decis Mak. 2013;13(S2):S4. doi:10.1186/1472-6947-13-S2-S4
  • Brehaut JC, Lott A, Fergusson DA, et al. Can patient decision aids help people make good decisions about participating in clinical trials? A study protocol. Implement Sci. 2008;3(1):38. doi:10.1186/1748-5908-3-38
  • Elliott D, Husbands S, Hamdy FC, et al. Understanding and improving recruitment to randomised controlled trials: qualitative research approaches. Eur Urol. 2017;72(5):789–798. doi:10.1016/j.eururo.2017.04.036
  • Kadam RA. Informed consent process: A step further towards making it meaningful! Perspect Clin Res. 2017;8(3):107–112.
  • Elmore JG, Ganschow PS, Geller BM. Communication between patients and providers and informed decision making. J Natl Cancer Inst Monogr. 2010;2010(41):204–209. doi:10.1093/jncimonographs/lgq038
  • Nishimura A, Carey J, Erwin PJ, et al. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013;14(1):28. doi:10.1186/1472-6939-14-28
  • Stacey CD. Development and Evaluation of a Breast Cancer Prevention Decision Aid to Address the Needs of Women Aged 50 and Older at High Risk for Breast Cancer. Ann Arbor: University of Ottawa (Canada); 2000:227.
  • Klein PD. Rethinking the multiplicity of cognitive resources and curricular representations: alternatives to ‘learning styles‘ and ‘multiple intelligences’. J Curric Stud. 2003;35(1):45–81. doi:10.1080/00220270210141891